Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

SL MEDITECH CO.

UEI: S92AR7KEA4U1CAGE: 965KF

SL MEDITECH CO. is a federal contractor, registered under UEI S92AR7KEA4U1 and CAGE code 965KF. It has been awarded $1,863,683 across 4 federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing and Unknown NAICS. Top awarding agencies include Department Of Defense and Defense Health Agency Hcd West.

Contact Information

Registration and classification details

Registration

UEI Code

S92AR7KEA4U1

CAGE Code

965KF

Entity Structure

Sole Proprietorship

Established

N/A

Business Classifications

2X

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing(Primary)
423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
532490Other Commercial and Industrial Machinery and Equipment Rental and Leasing
621511Medical Laboratories
621512Diagnostic Imaging Centers
+2 more

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

SL MEDITECH CO. specializes in the manufacturing of in-vitro diagnostic reagents and associated analyzer systems, with a focused expertise in hematology testing solutions for clinical and military medical environments. The company designs, produces, and delivers precision reagent kits and integrated...

SL MEDITECH CO. specializes in the manufacturing of in-vitro diagnostic reagents and associated analyzer systems, with a focused expertise in hematology testing solutions for clinical and military medical environments. The company designs, produces, and delivers precision reagent kits and integrated analyzer-compatible consumables that enable automated blood cell analysis, critical for rapid diagnostic decision-making in field hospitals and clinical laboratories. Their technical proficiency lies in assay formulation, quality-controlled reagent stability, and system interoperability with automated hematology platforms, ensuring compliance with clinical laboratory standards for accuracy and reproducibility. A key differentiator is their ability to tailor diagnostic solutions for distributed, resource-constrained settings, as evidenced by deployments supporting multiple clinics in Korea under U.S. Department of Defense requirements. The contractor maintains a consistent relationship with the Department of Defense, delivering mission-critical diagnostic materials that support operational readiness and troop health surveillance. Their work directly enables point-of-care and laboratory-based hematology testing in military medical facilities, reinforcing the DoD’s commitment to reliable, deployable diagnostic capabilities in austere environments. SL MEDITECH CO. operates exclusively within the in-vitro diagnostic substance manufacturing sector (NAICS 325413), positioning itself as a niche supplier of hematology-specific reagents for government and clinical use. The company’s market focus is on diagnostic systems requiring high specificity, batch consistency, and regulatory compliance, serving defense and allied healthcare infrastructure with mission-aligned product reliability. As a 2J-structured entity based in Seongnam-Si, Gyeonggi-do, the company functions as a specialized manufacturer without disclosed federal certifications. Its geographic presence supports regional logistics for Indo-Pacific defense medical operations, aligning its production and distribution capabilities with U.S. military medical supply chain needs in the region.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Defense$1.3M67.6%
Defense Health Agency Hcd West$603.6K32.4%
Awards by NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing$1.3M67.6%
- Unknown NAICS$603.6K32.4%
Awards by Agency Over Time
Awards by Place of Performance

Compete with SL MEDITECH CO.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for SL MEDITECH CO.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS

Open opportunities in SL MEDITECH CO.'s top NAICS codes and agencies

NAICS: 325413
New
DIBBS
TEST KIT, CHLAMYDIA TRA
Solicitation # SPE2DS-26-T-423P
Solicitation SPE2DS-26-T-423P, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for one test kit for the detection of Chlamydia trachomatis, identified by NSN 6550-01-725-3600. The kit is designed for in vitro diagnostic use to perform qualitative direct immunofluorescence tests on human urogenital and ophthalmic specimens, as well as for confirming Chlamydia in cell culture. Each kit must provide materials for 50 tests and include two positive control slides, mounting fluid, Chlamydia test reagent, and instructions for use. The required delivery date is September 14, 2026, with the place of performance and delivery located in San Antonio, Texas. The procurement falls under NAICS code 325413 and is subject to destination inspection and acceptance. Packaging must adhere to commercial standards, MIL-STD-2073-1E, and RP001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and the Hazard Communication Standard for hazardous materials. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system. Quotes must be submitted via the DIBBS portal by September 16, 2026, and the award may be processed through an automated system, with a price evaluation preference applied to HUBZone concerns.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Brand Name: Nitrous Oxide & Oxygen Delivery 50/50 System – NMCSD with Two (2) Cylinders (N2O and O2)
Solicitation # HT941026Q2080
Solicitation HT941026Q2080 is a firm-fixed-price request for quotes issued by the Defense Health Agency Healthcare Contracting Division-West for the procurement of five brand-name Porter Instruments nitrous oxide and oxygen delivery 50/50 systems. These systems, which must be FDA-cleared and include regulators, vacuum connectors, hoses, and disposable accessories, are intended for use at the Naval Medical Center San Diego Labor and Delivery Department and the Naval Hospital Camp Pendleton Maternal Infant Services Department. A critical technical requirement is that the systems must not require annual factory recalibration; failure to meet this specification will result in a technical unacceptable rating. The scope of work also includes both onsite and virtual training sessions for the Naval Hospital Camp Pendleton. The contract will be awarded based on Lowest Price Technically Acceptable procedures to a responsible quoter who is an original equipment manufacturer or an authorized dealer, distributor, reseller, or service provider. All items must be delivered in a single shipment within 90 days after receipt of order to the specified locations in San Diego and Camp Pendleton, California. Invoicing and payment will be processed through the Wide Area WorkFlow system upon government acceptance of the delivered items. Offerors must provide a technical compliance volume, including an OEM authorization letter and confirmation of the recalibration requirement, and must hold their pricing firm for 60 calendar days.
Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 561110
New
Federal
Integrated Referral Management and Appointing Center (IRMAC) Services
Solicitation # HT941026R2001
The Defense Health Agency Contracting Activity is seeking a single awardee for the Integrated Referral Management and Appointing Center (IRMAC) contract, an 8(a) set-aside procurement under NAICS code 561110. The contractor will provide non-personal services including centralized Patient Appointing Services (PAS), Referral Management Services (RMS), and Clear and Legible Report (CLR) accountability for Military Treatment Facilities in Hawaii and the Pacific Northwest. The awardee must operate from a single, contractor-furnished commercial facility located within 25 miles of a U.S. Military Treatment Facility. The period of performance consists of a 90-day transition period starting December 1, 2026, a base period through September 30, 2027, and four option periods extending through March 31, 2031. Evaluation is based on a best-value trade-off where Technical Quality and Past Performance are significantly more important than Price. Technical Quality is assessed on an acceptable/unacceptable basis across three sub-factors: Management and Technical Approach, Transition Plan, and Staffing Plan. Past Performance requires a minimum rating of Satisfactory Confidence for award consideration. The contract requires strict adherence to DHA directives, DoD antiterrorism standards, and cybersecurity compliance, including RMF documentation and ATO approval within 30 days of award. While the government intends to proceed with the solicitation, the final contract award will be withheld until at least November 23, 2026, pending the resolution of a GAO protest.
Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 11 days
View Details
NAICS: 334516
New
Federal
FY26 Lab Consolidation for Coagulation CPRR Effort
Solicitation # HT941026Q2004
Solicitation HT941026Q2004 is an unrestricted, full and open competition request for a cost per reportable result contract to provide coagulation analyzers, reagents, and consumables for multiple military treatment facilities across the Pacific Rim, Indo Pacific, Continental, Central, and West networks. The requirement includes the provision of new, FDA-approved equipment capable of bidirectional interfacing with electronic health records and laboratory information systems. The contract structure consists of a base year and four option years, with a total estimated workload of over 104,000 tests annually, including high volumes of Prothrombin Time and Activated Partial Thromboplastin Time assays. The award will be determined on a Best Value Tradeoff basis, prioritizing non-price factors—Technical, Past Performance, and Information Assurance—over price. Key performance requirements include a 95 percent monthly instrument uptime and a transition period not exceeding 60 days from award. Contractors must comply with strict cybersecurity standards, including the Risk Management Framework and the submission of a Medical Device and Equipment Risk Assessment questionnaire. Maintenance and support must be provided by OEM-trained, English-speaking personnel, and all equipment must be delivered FOB Destination. The most recent update, Amendment 0008, revised the statement of work to include a transition plan deliverable and updated the delivery start dates and pricing sheets.
Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 6 days
View Details